|
Volumn 36, Issue 3, 2002, Pages 517-520
|
Granulocyte macrophage-colony stimulating factor and oral mucositis
|
Author keywords
Granulocyte macrophage colony stimulating factor; Oral mucositis
|
Indexed keywords
ACICLOVIR;
ALKYLATING AGENT;
ANTHRACYCLINE;
ANTIFUNGAL AGENT;
ANTIMETABOLITE;
ANTINEOPLASTIC AGENT;
ANTINEOPLASTIC ANTIBIOTIC;
BICARBONATE;
CHLORHEXIDINE;
CISPLATIN;
CYCLOPHOSPHAMIDE;
CYTARABINE;
ETOPOSIDE;
FLUOROURACIL;
FOLINIC ACID;
GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR;
SODIUM CHLORIDE;
TAXANE DERIVATIVE;
THIOTEPA;
VINCA ALKALOID;
ADOLESCENT;
ADULT;
CANCER CHEMOTHERAPY;
CANCER RADIOTHERAPY;
CHILD;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
CROSSOVER PROCEDURE;
DISEASE DURATION;
DISEASE SEVERITY;
DOUBLE BLIND PROCEDURE;
DRUG EFFICACY;
DRUG SAFETY;
HEAD AND NECK CANCER;
HUMAN;
MEDLINE;
MOUTH MUCOSA;
MOUTHWASH;
MUCOSA INFLAMMATION;
PRIORITY JOURNAL;
PROPHYLAXIS;
RANDOMIZED CONTROLLED TRIAL;
REVIEW;
ADOLESCENT;
ADULT;
CHILD;
CHILD, PRESCHOOL;
GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR;
HUMANS;
MOUTH MUCOSA;
RANDOMIZED CONTROLLED TRIALS;
SEVERITY OF ILLNESS INDEX;
STOMATITIS;
|
EID: 0036198812
PISSN: 10600280
EISSN: None
Source Type: Journal
DOI: 10.1345/aph.10311 Document Type: Review |
Times cited : (12)
|
References (15)
|